A Sequential Phase 2b and Phase 3 Study to Evaluate the Efficacy and Safety of AZD4831 in Participants with Heart Failure with Left Ventricular Ejection Fraction > 40% (ENDEAVOR)

Project: Research project

Project Details

StatusActive
Effective start/end date5/17/24 → 7/31/26

Funding

  • AstraZeneca UK Limited (ENDEAVOR D6580C00010)